Shanghai, China

Xiu Wang


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Xiu Wang

Introduction

Xiu Wang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target voltage-gated sodium channels. With a total of 3 patents, her work has the potential to impact the treatment of various neurological disorders.

Latest Patents

Xiu Wang's latest patents include innovative compounds designed to block Nav 1.7 ion channels found in peripheral and sympathetic neurons. One of her notable patents is for hydroxypyrrolidine-substituted arylsulfonamide compounds, which are disclosed as having properties for treating cough, itch, and neuropathic pain disorders. Another significant patent involves bicycloamine-substituted-N-benzenesulfonamide compounds, which also target Na1.7 ion channels and are aimed at treating neuropathic pain disorders.

Career Highlights

Throughout her career, Xiu Wang has worked with reputable companies such as Merck Sharp & Dohme Corporation and Shanghai Magic Wheels Sporting Goods Co., Ltd. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical formulations and drug development.

Collaborations

Xiu Wang has collaborated with notable colleagues, including Mark E. Layton and Anthony J. Roecker. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Xiu Wang's contributions to the field of pharmaceutical chemistry are noteworthy, particularly her advancements in compounds targeting sodium channels. Her work holds promise for improving treatments for various neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…